We have previously reported an association of an early decrease of BAFF levels with cumulative glucocorticoid doses at the beginning of treatment in early myositis cases [17], and our current findings provide further support for the sensitivity of BAFF production to glucocorticoid treatment in myositis. This evidence concerns the gene TNFSF13B and myositis disease.